UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):October 12, 2018(October 12, 2018)
Heyu Biological Technology Corporation
(Exact Name of Registrant as Specified in its Charter)
Nevada |
| 000-26731 |
| 87-0627910 |
(State or Other Jurisdiction of Incorporation)
|
| (Commission File Number) |
| (IRS Employer Identification Number) |
4th Floor, No. 10 Building, Xinglin Bay Business Operation Center,
Jimei District, Xiamen City,
Fujian Province, China 361022
(Address of Principal Executive Offices, Zip Code)
Registrant’s telephone number, including area code:(86) 158 5924 0902
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of New Director – Kwee Huwa Tan
On October 12, 2018, Ms. Kwee Huwa Tan was appointed to the Board of Directors of the Company to serve as a director of the Company.
Ms. Kwee Huwa Tan, age 54, is a sales & marketing expert with a strong entrepreneurial spirit. Since April 2017, Ms. Tan has been a director for Heyu Leisure Holidays Corporation, a U.S. public company managing budget hotels in China. In 2012, Ms. Tan founded Isbel Beauty Centre., a provider of primer skin care products in Malaysia, and she has been the Chief Executive Officer of Isbel Beauty Centre since 2012. Ms. Tan has also served as the Chief Advisor to Heyu Biological Technology Corporation (Xiamen) since 2013 where she was tasked with developing networking opportunities, analyzing profitability of products and market potentials and cultivating prospective clients. Ms. Tan earned her bachelor degree in Business Administration from Ansted University in Malaysia in 1986.
Ms. Tan does not have any family relationship with any director or executive officer of the Company and has not been involved in any transaction with the Company during the past two years that would require disclosure under Item 404(a) of Regulation S-K.
1 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Heyu Biological Technology Corporation | ||
By: | /s/Ban Siong Ang | |
Name: Title: | Ban Siong Ang Chief Executive Officer | |
Date: | October 12, 2018 | |
2 |